baber/WOPTO huggingface dataset:
Patent AU-2022200870-B2 (AU)
Title: Materials and methods for increasing the tocopherol content in seed oil
Inventor: ANDRE CARL
IPC: C12N15/82
Filed: 2022-02-10
Granted: 2023-06-15
Abstract: MATERIALS AND METHODS FOR INCREASING THE TOCOPHEROL CONTENT IN SEED OIL 
5 The present invention relates generally to the field of molecular biology and concerns increasing 
the tocopherol content of a plant relative to a control plant, comprising expressing in a plant at 
least one polynucleotide encoding a delta-12-desaturase, at least one polynucleotide encoding a 
delta-6-desaturase, at least one polynucleotide encoding a delta-6-elongase, and at least one 
polynucleotide encoding a delta-5-desaturase. The present invention also relates to methods for 
0 the manufacture of oil, fatty acid- or lipids-containing compositions, and to such oils and lipids as 
such.
Patent JP-4382949-B2 (JP)
IPC: H01G11/74
Filed: 2000-02-29
Granted: 2009-12-16
Abstract: PROBLEM TO BE SOLVED: To provide a multilayer electric double-layer capacitor which is low in internal resistance, high in electrostatic capacity and high in productivity. SOLUTION: A cell 14 for an electric double-layer capacitor is constituted into a structure, where an almost rectangle-shaped laminate formed by laminating a polarized electrode 3 on the surface on at least one side of the surfaces of a current-collecting body 2 is housed between two almost rectangle-shaped separators 5 and 5 and at the same time, a conductor 1 for forming terminals is provided on at least a part of the side parts of the body 2 and the conductor 1 is folded up where the conductor 1 pinches the end parts of the separators 5 and 5 to form the terminals 6 on the end parts of the separators 5 and 5 and a multilayer electric double-layer capacitor 20 is manufactured into a structure that the capacitor 20 is provided with a plurality of the cells 14.
Patent JP-3921921-B2 (JP)
IPC: H01G4/32
Filed: 2000-04-26
Granted: 2007-05-30
Abstract: PROBLEM TO BE SOLVED: To provide a capacitor base body comprised of a capacitor element where the ends of a pair of electrode foils are mutually exposed on the opposite side, which can ensure an insulation creeping distance between the capacitor elements and is highly reliable because of no short circuit. SOLUTION: Insulation papers 8, 8a, and 8b are bent to cover the entire circumferential surface of a half side of a capacitor element between capacitor elements 5, 5a and 5b and between capacitor elements 5a and 5b and assembled iron plates 6a and 6b, and their bend tip ends are extended to the outer circumferential surface of the adjoining capacitor element, and then they are inserted therebetween and assembled. At this time, an insulation spacer 9 is inserted together with the capacitor element to a position where the bending direction of the insulation paper is inversed, thereby eliminating folding of the end of the insulation paper.
Patent JP-3668795-B2 (JP)
IPC: A61P9/00
Filed: 1998-09-14
Granted: 2005-07-06
Abstract: The present invention concerns isolated nucleic acid molecules encoding the novel TIE ligand homologues NL2, NL3 and NL6 (FLS139), the proteins encoded by such nucleic acid molecules, as well as methods and means for making and using such nucleic acid and protein molecules.
Patent JP-3586192-B2 (JP)
IPC: G01N21/03
Filed: 1998-09-27
Granted: 2004-11-10
Abstract: The present invention relates to a method and apparatus for measuring the lipid peroxidation extent in biological fluids and suspensions of tissues, in which a specifically prepared lipids containing sample is exposed to heat so as to induce thermochemiluminescence light which is emitted by the sample and is enhanced to an amount which can be detected by a special purpose photo detector. The measurement of the light allows to conclude about the content of peroxides and subsequently to obtain accurate assessment of lipid peroxidation.
Patent JP-4647096-B2 (JP)
IPC: G06F9/445
Filed: 1998-11-16
Granted: 2011-03-09
Abstract: A method and system for configuring computers to connect to networks using network connection objects. For each connection to a network, configuration information for connecting to that network is maintained within a connection object. Such configuration information may include device, protocol, and other computer and network property information along with binding information therefor. Connection objects may be stored as files or the like independent of a running network configuration, and be applied to the running configuration to change the network configuration. Also included is a process to reconcile networking components identified in a connection object with those available on a given system.
Patent JP-4303419-B2 (JP)
IPC: A61L27/00
Filed: 1998-12-04
Granted: 2009-07-29
Abstract: The three dimensional device is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery. The device is formed from a multi-stranded microcable having a plurality of flexible strands of a shape memory material and at least one radiopaque strand. The flexible strands in a multi-stranded micro-cable of the device can be helically wound, or can be configured as parallel, longitudinal strands, and can also be formed to have a secondary, three dimensional therapeutic configuration, such as helical, conical, spherical, or other geometric shapes. The strands can be made of a shape memory nickel titanium alloy, that is highly flexible at a temperature appropriate for introduction into the body via a catheter, and that after placement will take on the therapeutic shape. The device can also include a therapeutic agent, and can be bundled by an outer cover to constrain the strands of the micro-cable about a longitudinal axis to produce a composite banded cable. The radiopaque strand can have a core strand with a plurality of intermittently spaced apart enlarged radiopaque portions that may be a plurality of beads of radiopaque material spaced apart and mounted on the core strand, or a plurality of coils intermittently wound about and spaced apart on the core strand. A polyhedral occlusive device is also provided, adapted to be inserted into a portion of a vasculature for occluding a portion of the vasculature, for use in interventional therapy and vascular surgery. One or more therapeutic fibers can also be woven into the coil to enhance treatment of the site after placement of the device. <IMAGE>
Patent JP-3899508-B2 (JP)
IPC: F16F9/32
Filed: 1999-02-08
Granted: 2007-03-28
Abstract: A gas spring device is provided with a safe and effective way to reduce to zero the velocity of a piston rod which is traveling at a high velocity in the gas spring device during a failure of the gas spring device. This achieved by stopping the piston rod in a controlled manner through a stepwise reduction in its energy and velocity to keep the force on the piston to a minimum at all times during the failure. The reduction in energy is caused by a plurality of frangible components associated with the gas spring device which are designed to break during a failure, thereby dissipating the kinetic energy of the piston rod.
Patent JP-4637352-B2 (JP)
IPC: A61P3/10
Filed: 1999-06-15
Granted: 2011-02-23
Abstract: Methods of use of pharmaceutical compositions and novel peptides which are conformationally constrained backbone cyclized somatostatin analogs, having somatostatin receptor subtype selectivity, are disclosed. These patterns or receptor subtype selectivity provide compounds having improved therapeutic utility. Methods for synthesizing the somatostatin analogs and for screening of the somatostatin analogs are also disclosed. Furthermore, pharmaceutical compositions comprising somatostatin analogs are disclosed.
Patent JP-4358994-B2 (JP)
IPC: H04W84/12
Filed: 1998-12-18
Granted: 2009-11-04
Abstract: The present invention proposes a method for traffic load control in a telecommunication network consisting of at least one radio terminal (MS) and at least one radio transceiver device (BS), each radio transceiver device (BS) defining a cell of said network being controlled by a network control device (RNC); comprising the steps of: setting a first reference load value for the load of a respective cell; monitoring the load of said respective cell, and in response to the load exceeding the first reference load value, manipulating the power control to decrease the transmission power levels in the cell. The present invention thus proposes a fast load control method in that during a situation in which a certain reference load value is exceeded, the load is controlled per base station sector by affecting, e.g. transmit power commands. In addition, such load reductions can be supplemented by re-negotiating bit rates, for example. With the proposed method a necessary load margin can be reduced which advantageously increases the system capacity.
Patent JP-4700194-B2 (JP)
IPC: A61P1/16
Filed: 2000-01-22
Granted: 2011-06-15
Abstract: The present invention relates to compounds of formula I: wherein R<SUP>1</SUP>, R<SUP>2</SUP>, and R<SUP>3 </SUP>have the meanings indicated in the specification, which are valuable pharmaceutical active compounds for the therapy and prophylaxis of diseases such as cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficiency, thromboses, or atherosclerosis. Compounds of formula I have the ability to modulate the endogenous production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the therapy and prophylaxis of disease states which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for the preparation of compounds of formula I, methods of therapy and prophylaxis of the designated disease states and for the production of pharmaceuticals therefor, and pharmaceutical compositions which comprise at least one compound of formula I.
Patent JP-4709393-B2 (JP)
IPC: A61P43/00
Filed: 2000-04-12
Granted: 2011-06-22
Abstract: The present invention relates to a method for promoting blood vessel formation in tissues and organs. In particular, the method relates to implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues. The three-dimensional stromal tissue of the present invention may be used in a variety of applications including, but not limited to, promoting repair of and regeneration of damaged cardiac muscle, promoting vascularization and healing during cardiac surgery, promoting blood vessel formation at anastomosis sites, and promoting vascularization and repair of damaged skeletal muscle, smooth muscle or connective tissue.
Patent JP-3659890-B2 (JP)
IPC: G01N33/53
Filed: 2000-04-11
Granted: 2005-06-15
Abstract: The present invention provides a method and apparatus for dispensing small volumes of selected substances, such as biological reagents or samples, onto substrates. According to one general embodiment, a plurality of spaced, tandemly-arranged substrates are advanced, e.g., by way of a conveyor, along a transport pathway extending over a reagent-supply location, such as a reservoir supported at a fixed position in a base. From a position over the reagent-supply location and the pathway, a reagent-transfer instrument, or tip, is extended along an axis through an intervening region, e.g., an opening defined by a surface of the conveyor, separating an adjacent pair of advancing substrates to contact reagent held at the reagent-supply location. The reagent-transfer instrument is then withdrawn, along with a portion of such reagent, through the intervening region to a position above the transport pathway. Once the conveyor has advanced a selected substrate, upstream of the intervening region, to a position aligned with the axis of the reagent-transfer instrument, a selected amount of reagent is transferred from the instrument onto a selected site of the substrate. Advantageously, the apparatus and method are readily adaptable for the production of micro-arrays having a great number of closely spaced spots.
Patent JP-3277179-B2 (JP)
IPC: G01D15/16
Filed: 2001-01-24
Granted: 2002-04-22
Abstract: A substrate for liquid ejection includes a built-in energy generating element for generating thermal energy, a built-in electrode wiring portion for supplying an electric signal to the energy generating element, and a built-in diode or transistor for detecting a temperature of the substrate. <IMAGE>
Patent JP-3984462-B2 (JP)
IPC: F16C33/10
Filed: 2001-11-26
Granted: 2007-10-03
Abstract: A dynamic pressure bearing device including a dynamic pressure bearing member, a thrust dynamic pressure bearing member, and a fluid sealing section for preventing lubrication fluid in the thrust dynamic pressure bearing member from leaking outside, provided adjacent to an outer side section in a radial direction of the thrust dynamic pressure bearing member and defined by an outer circumference wall surface of the dynamic pressure bearing member. The outer circumference wall surface has an inclined outer surface having diameters that decrease in the axial direction, and a ridge section located removed in the axial direction from the fluid sealing section, wherein the outer circumference wall surface is receded in the radial direction along the ridge section than the inclined outer surface of the dynamic pressure bearing member.
Patent JP-4536979-B2 (JP)
IPC: G05B19/4103
Filed: 2000-08-12
Granted: 2010-09-01
Abstract: An apparatus and a method for generating a set-point value for triggering at least one drive mechanism, in particular for a machine tool, are proposed, wherein, in a parts program (20) for describing a path of motion of a tool (12) movable by the at least one drive mechanism (18), at least two parts program positions (X1, Y1, Z1; X2, Y2, Z2; X3, Y3, Z3) are stored in memory. A controller (18) which from the parts program (20) ascertains at least one drive mechanism set-point value (VA(S)) for triggering the drive mechanism (18). Means (18) are provided for ascertaining a distance (S) that is located between the at least two parts program positions (X1, Y1, Z1; X3, Y3, Z3) and for generating a drive mechanism set-point value (VA(S)) as a function of the distance (S) and of at least one parts program parameter (V1, V2).
Patent JP-4680458-B2 (JP)
IPC: H04L27/20
Filed: 2000-09-14
Granted: 2011-05-11
Abstract: Techniques to adjust the phase rotation of a modulated signal to compensate for the phase rotation introduced by circuit elements associated with the transmit signal path. In one implementation, at least one control signal is received, with each control signal being provided to adjust a particular characteristic (e.g., gain, bias current) of one or more circuit elements (e.g., VGA, PA) associated with the transmit signal path. The circuit elements can be located directly in, or operatively coupled to, the transmit signal path. A phase rotation corresponding to an operating state defined by the received control signal(s) is then determined, and the phase of the modulated signal is rotated by an amount related to the determined phase rotation. The phase rotation compensation can be performed at various locations along the transmit signal path by rotating either the data, the PN sequences used to spectrally spread the data, or the carrier signals used to modulate the data.
Patent JP-5106731-B2 (JP)
IPC: G01G13/00
Filed: 2000-11-03
Granted: 2012-12-26
Abstract: There is disclosed an apparatus and method which is capable of dispensing very small (typically less than 5 mg) quantities of particles to a high accuracy in a repeatable way and without undue wastage. Also, the need for advanced particle formulation is reduced. The apparatus comprises a closed loop control system which uses an electro-mechanical actuator to deliver impact energy to a supply of particles initially held on a sieve in a hopper. The impact energy causes a small number of particles to fall through the sieve and onto a weight measuring balance. The weight obtained is scrutinised by a processor to see if further actuations are required. In preferred embodiments, the energy of actuation is varied in accordance with the rate of dispensation calculated by the processor. Also, a correction amount can be obtained to take account of the fact that the balance can take a considerable amount of time to settle to its final value.
Patent JP-4328050-B2 (JP)
IPC: A61P7/06
Filed: 2001-01-22
Granted: 2009-09-09
Abstract: Methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected by administering activated T cells that recognize an antigen of Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration within the nervous system. In another embodiment, treatment involves administering Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration in the nervous system, either the central nervous system or the peripheral nervous system. The activated T cells, which have been activated by the presence of Cop 1 or a Cop 1-related peptide or polypeptide, can be administered alone or in combination with Cop 1 or a Cop 1-related peptide or polypeptide.
Patent JP-4739633-B2 (JP)
IPC: G11B15/06
Filed: 2001-02-07
Granted: 2011-08-03
Abstract: A recording and/or reproducing apparatus (1) adapted to receive a record carrier (4) advantageously includes a transponder communication device (35) having a planiform station transmission coil (37) for the contactless communication with a record record-carrier transmission coil (50) combined with the record carrier (4), and includes holding means (51) for holding the station transmission coil (37) which extend away from the station transmission coil (37) into the space which is remote from the record-carrier transmission coil (50).
Patent JP-5421509-B2 (JP)
IPC: F25B1/00
Filed: 2001-05-30
Granted: 2014-02-19
Abstract: Heating/defrost construction of very low temperature refrigeration system (100) having a defrost supply circuit (176, 178, 180) and a defrost return bypass circuit (186, 188, 190) optimizing the heating/defrost cycle, preventing overload (excessive pressure) of its refrigeration process and protecting components from damaging temperatures. The defrost cycle operates continuously, when required, and provides a shorter recovery period between heating/defrost and cooling operating modes. The rate of the temperature change during cool down or warm up is controlled in an open loop fashion by controlled refrigerant flow in bypass circuits (178, 190).
Patent JP-4263476-B2 (JP)
IPC: G06F9/445
Filed: 2001-04-30
Granted: 2009-05-13
Abstract: A system and method is provided for providing security to components or assemblies employed by application programs during runtime. Assemblies carry version information that can be used to enforce the versioning rules described by the application program. At runtime, version numbers requested by the application programs are compared with those version numbers of the assemblies that are actually found. In addition to comparing version numbers, the present invention offers a stricter form of version checking based on cryptographic hashes. An assembly is provided with module information that contains a list of the files that make up the assembly. Part of the information recorded about each module is a hash of the module's contents at the time the manifest was built. An assembly referencing another assembly computes the hash of the manifest of the referenced assembly. An assembly manifest may include dependency information, which is information about other assemblies that the assembly depends on or references. Part of the information stored as part of an assembly reference or manifest is a hash of the dependent assembly's manifest.
Patent JP-5189723-B2 (JP)
IPC: A61K39/00
Filed: 2001-09-18
Granted: 2013-04-24
Abstract: Glucagon-like peptide-2, its analogues and derivatives, for use in the treatment of hyperparathyroidism.
Patent JP-4308517-B2 (JP)
IPC: B01J37/03
Filed: 2001-10-01
Granted: 2009-08-05
Abstract: The invention relates to a supported platinum group metal catalyst obtainable by controlled electroless deposition of at least one platinum group metal from a deposition solution which comprises i) at least one homogeneously dissolved platinum group metal compound, ii) a reducing agent and iii) at least one control agent selected from isopolyacids and heteropolyacids of niobium, tantalum, molybdenum, tungsten and vanadium or their salts.
Patent JP-4250416-B2 (JP)
IPC: A61P17/06
Filed: 2001-10-16
Granted: 2009-04-08
Abstract: Pteridine compounds of formula (I) processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in the treatment of inflammatory diseases such as psoriasis, rheumatoid arthritis, diseases in which angiogenesis is assocated with raised CXCR2 chemokine levels (diabetic retinopathy) and COPD. The compounds are ligands for chemokine receptors and medical indications mentioned in the description include: diseases of the respiratory tract (COPDD, asthma, bronchitis, rhinitis, fibroid lung, pneumonia, etc.), diseases of the bones and joints (arthritis, etc.), skin-diseases (psoriasis, etc), diseases of the gastrointestinal tract, diseases in other tissues and systemic disease (multipe sclerosis, atherosclerosis, AIDS, type 1 diabetes, leprosy, sepsis, etc.), allograft rejection, cancers, cystic fibrosis, stroke, burn wounds, skin ulcers, reproductive disease and more.
Patent JP-4282322-B2 (JP)
IPC: A61K47/06
Filed: 2001-11-09
Granted: 2009-06-17
Abstract: Drug compositions containing one or more tiotropium salts and one or more salmeterol salts, are new. Drug compositions containing one or more tiotropium salts and one or more salmeterol salts, are new. The salts can be present in the form of enantiomers, enantiomer mixtures or racemates as well as in the form of solvates or hydrates. The compositions may also contain a pharmaceutical adjuvant. ACTIVITY : Antiasthmatic. MECHANISM OF ACTION : Anticholinergic; beta -mimetic.
Patent JP-4304982-B2 (JP)
IPC: A61P1/04
Filed: 2002-03-19
Granted: 2009-07-29
Abstract: Pharmaceutical products, foods or drinks or feeds and the like are provided, using lysine as the active ingredient of agents against stress-induced diseases, particularly the active ingredient of preventive agents therefor. These agents are highly effective for preventing, ameliorating, and therapeutically treating stress-induced diseases such as anxiety disorders, irritable bowel syndrome and gastric ulcer. Agents for stress - induced diseases are also provided. Further, the present invention provides a method for suppressing stress and a use of lysine for these agents, pharmaceutical drugs and the like.
Patent JP-4393080-B2 (JP)
IPC: F21V8/00
Filed: 2003-02-21
Granted: 2010-01-06
Abstract: <P>PROBLEM TO BE SOLVED: To provide a liquid crystal display in which a light emitting FPC (flexible print circuit) is prevented from dropping or slipping off from the connector of a driving FPC.  <P>SOLUTION: The upper end edge of the driving FPC 11 is connected to the lower end edge on the surface side of the array substrate 4 of an LCD cell 2. A back light 21 is disposed with the light emitting face 27 opposed to the back face side of the LCD cell 2. A connecting chip 32 in the upper end of the light emitting FPC 31 which energizes a light emitting diode 24 of the back light 21 is connected to the lower end edge of the light emitting face 27 of the back light 21. This reduces the discrepancy of the leading position between the driving FPC 11 and the light emitting FPC 31. The center part 35 of the light emitting FPC 11 is formed into an S-shape in the front view so that the distance between both ends can be increased or decreased. When the driving FPC 11 and the light emitting FPC 31 are folded or unfolded, the center part of the light emitting FPC 31 stretches or shrinks in the longitudinal direction.  <P>COPYRIGHT: (C)2004,JPO&NCIPI